Business Standard

Mavens Biotech standalone net profit declines 33.33% in the September 2015 quarter

Image

Capital Market

Sales rise 16.67% to Rs 0.21 crore

Net profit of Mavens Biotech declined 33.33% to Rs 0.02 crore in the quarter ended September 2015 as against Rs 0.03 crore during the previous quarter ended September 2014. Sales rose 16.67% to Rs 0.21 crore in the quarter ended September 2015 as against Rs 0.18 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales0.210.18 17 OPM %28.5727.78 -PBDT0.060.07 -14 PBT0.020.03 -33 NP0.020.03 -33

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 13 2015 | 4:54 PM IST

Explore News